OneMedNet Corp
Data quality: 100%
$0.83
▲
$0.01
(1.05%)
Mkt Cap: 43.68 M
Price
$0.84
Mkt Cap
43.68 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -7.52 M
Capital efficient — spends only 0.96% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)111.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-206.11%
Op. Margin-711.33%
Safety
Debt / Equity
N/A
Current Ratio0.29
Interest Coverage-144.28
Valuation
PE (TTM)
-15.60
Below sector avg (-1.19)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (515 peers)
Peer Comparison
vs Services sector median (515 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -15.6 | -1.2 |
| P/B | — | 1.4 |
| ROE % | — | -16.0 |
| Net Margin % | -206.1 | -19.4 |
| Rev Growth 5Y % | — | 4.2 |
| D/E | — | 0.4 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2026 | — | 1.57 M | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 111.35% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.36 M | Net Income (TTM) | -2.80 M |
| ROE | N/A | ROA | -145.77% |
| Gross Margin | -37.01% | Operating Margin | -711.33% |
| Net Margin | -206.11% | Free Cash Flow (TTM) | -7.52 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.29 |
| Interest Coverage | -144.28 | Asset Turnover | 0.71 |
| Working Capital | -3.56 M | Tangible Book Value | -3.94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -15.60 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 32.14 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -17.21% | ||
| Market Cap | 43.68 M | Enterprise Value | 48.17 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.06 | Revenue / Share | 0.03 |
| FCF / Share | -0.14 | OCF / Share | -0.14 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.96% | FCF Conversion | 268.33% |
| SBC-Adj. FCF | -8.27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.36 M | 643,000.0 | — | 1.02 M | — |
| Net Income | -2.80 M | -10.13 M | 336,658.0 | -23.21 M | 5.14 M |
| EPS (Diluted) | -0.06 | -0.36 | 0.03 | -0.98 | — |
| Gross Profit | -503,000.0 | -281,000.0 | — | -127,900.0 | — |
| Operating Income | -9.67 M | -9.61 M | -5.31 M | -8.37 M | -585,405.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 1.52 M | 1.47 M | — | 1.63 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 65,000.0 | 57,000.0 | — | 27,983.0 | — |
| Interest Expense | 67,000.0 | 147,000.0 | — | 749,213.0 | — |
| Income Tax | 1,000.0 | 2,000.0 | 214,850.0 | 18,000.0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2022 | FY2023 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.15 M | 3.73 M | 29.06 M | 463,057.0 | 117.86 M |
| Total Liabilities | 5.12 M | 19.68 M | 9.12 M | 13.32 M | 9.17 M |
| Shareholders' Equity | -2.97 M | -15.95 M | -8.81 M | -12.86 M | -8.61 M |
| Total Debt | 220,000.0 | 4.64 M | — | — | — |
| Cash & Equivalents | 585,000.0 | 172,000.0 | 30,870.0 | 47,008.0 | 453,151.0 |
| Current Assets | 2.10 M | 3.62 M | 30,870.0 | 364,186.0 | 536,212.0 |
| Current Liabilities | 4.83 M | 19.23 M | 1.98 M | 12.83 M | 289,980.0 |
{"event":"ticker_viewed","properties":{"ticker":"ONMD","listing_kind":"stock","pathname":"/stocks/onmd","exchange":"NASDAQ","country":"US"}}